Company Data
ADC Therapeutics SA
Ticker
ADCT
Current Price
$2.65 6%
Market Cap
$262.8M
Price Target
Refer to Report
Volume
1.1M
52wk Range
$1.05 - $4.13
Overview
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company’s product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.